🔬 100% Non-Invasive Toronto University Hospital

Light That Sees
What No Instrument
Ever Could

Advance Med Pro has developed five proprietary photonic technologies that diagnose, monitor, and heal — all through the skin, without a single needle or incision. The future of medicine is illuminated.

47+ Biomarkers Detected
5 Breakthrough Patents
98% Diagnostic Accuracy
0 Invasive Procedures
Who We Are

Redefining Medical Sensing
From the Inside Out

Founded within the innovation labs of Toronto University Hospital, Advance Med Pro brings together photonic physicists, oncologists, neurologists, and AI engineers to build a new era of painless precision diagnostics.

🌊

Photonic Innovation

Our sensors harness multi-spectral light from UV to near-infrared, penetrating tissue at precise depths to extract biological data never before accessible without surgery.

🧠

AI-Driven Analysis

Machine learning models trained on over 2.4 million patient scans decode spectral signatures into clinically actionable biomarker readings in under 3 seconds.

🏥

Hospital-Grade Accuracy

Validated across 14 clinical departments at Toronto University Hospital, our devices meet or exceed the accuracy benchmarks of invasive blood sampling for 47 key biomarkers.

🔒

Zero Patient Risk

No needles. No contrast agents. No ionizing radiation. Every Advance Med Pro technology is certified non-invasive under Health Canada Class II Medical Device standards.

Real-Time Results

Continuous monitoring streams live biomarker data to clinical dashboards — enabling instant interventions instead of waiting hours for lab results.

🌐

Wearable & Remote

Our wearable sensor patches let patients be monitored at home with hospital-grade precision, reducing admissions and cutting healthcare costs by up to 60%.

Exclusive Innovations

Five Technologies the World
Has Never Seen

These are not iterations of existing tools. These are entirely new categories of medical sensing, developed exclusively by Advance Med Pro.

⚛️

QuantaFlux Spectral Mapping

QSM · Patent Pending CA-2024-0891

Quantum dot sensor arrays emit precisely tuned multi-wavelength light that maps cellular oxygen metabolism at the mitochondrial level — through intact skin — with sub-micron spatial resolution.

Quantum Dots O₂ Metabolism World First
🌟

BioLumin Resonance Imaging

BLRI · Patent Pending CA-2024-0892

Applying bioluminescent resonance energy transfer principles externally, BLRI detects tumor microenvironments and inflammatory cascades — no contrast agents, no radiation, just light.

BRET Principle Oncology World First
🎨

ChromaDerm Analysis

CDA · Patent Pending CA-2024-0893

A single 0.4-second light pass through the skin simultaneously identifies 47 biomarkers including glucose, cortisol, clotting factors, hydration, and inflammatory cytokines via AI spectral decoding.

47 Biomarkers AI Spectral AI World First
💠

PhoTissue Wave Therapy

PWT · Patent Pending CA-2024-0894

Adaptive near-infrared pulsed waveforms that simultaneously diagnose tissue damage and trigger photobiomodulation healing cascades in a single device — diagnosis and treatment unified.

NIR Therapy Tissue Repair World First
🧿

NeuroPulse Optical Mapping

NPOM · Patent Pending CA-2024-0895

A non-contact photonic scanner that reads cortical blood-flow patterns through the intact skull, mapping neural activity with millimetre precision — no MRI machine required.

Neurology Skull Penetration World First
Clinical Voices

What Our Partners Say

"The ChromaDerm device replaced seven separate blood tests in our endocrinology ward. We get results in seconds instead of hours. The patients are amazed — and frankly, so are we."

DR
Dr. Rajani Mehta
Chief of Endocrinology, Toronto University Hospital

"NeuroPulse Optical Mapping has transformed how we monitor post-surgical brain trauma patients. Continuous, non-invasive cortical mapping at the bedside — it's extraordinary science."

PL
Prof. David Liang
Director of Neurosurgery, UHN Toronto

"BLRI caught a recurrence in one of our patients three weeks before it appeared on PET scans. That is not incremental improvement — that is a paradigm shift in oncology."

SC
Dr. Simone Carvalho
Oncology Research Lead, Princess Margaret Cancer Centre

Ready to See Medicine
in a New Light?

Partner with Advance Med Pro to bring non-invasive photonic diagnostics to your department or institution.